Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes].

Zhonghua zhong liu za zhi [Chinese journal of oncology] - 1 Sept 2014

Liu Yan, Zhang Xiaobei, Yu Feng, Liu Jingjing, Zhang Min, Zhang Sheng, Hao Xiaomeng, Zhang Jin

Abstract excerpt

OBJECTIVE: This study was conducted to analyze the Ki-67 expression before and after neoadjuvant chemotherapy and clinicopathological characteristics of different biological breast cancer phenotypes. The significance and prognostic predictive value of the changes of Ki-67 expression in different biological breast cancer phenotypes were analyzed. METHODS: A regression analysis was performed on 178 patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Immunohistochemistry

Share to Phenotype

Share to Prognosis

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Source

Identifiers

PMID: 25564057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes].PMID 25564057Read ↗

[Evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: correlation with molecular phenotype].Semantic proximity Read ↗

Ki-67 as a prognostic marker according to breast cancer molecular subtypeSemantic proximity Read ↗

Ki-67 Expression by Immunohistochemistry and Quantitative Real-Time Polymerase Chain Reaction as Predictor of Clinical Response to Neoadjuvant Chemotherapy in Locally Advanced Breast CancerSemantic proximity Read ↗

Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis.Semantic proximity Read ↗

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.Semantic proximity Read ↗

[Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy].Semantic proximity Read ↗

Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.Semantic proximity Read ↗

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.Semantic proximity Read ↗

The Role of Ki-67 in HR+/HER2- Breast Cancer: a Real-world Study of 956 PatientsSemantic proximity Read ↗

Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype.Semantic proximity Read ↗

Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimensSemantic proximity Read ↗

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.